Jones TH - Search Results

1

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. Kapoor D, et al. Among authors: jones th. Eur J Endocrinol. 2007 May;156(5):595-602. doi: 10.1530/EJE-06-0737. Eur J Endocrinol. 2007. PMID: 17468196 Clinical Trial.

2

Testosterone replacement therapy: current trends and future directions.

Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM, Wu FC. Nieschlag E, et al. Among authors: jones th. Hum Reprod Update. 2004 Sep-Oct;10(5):409-19. doi: 10.1093/humupd/dmh035. Epub 2004 Aug 5. Hum Reprod Update. 2004. PMID: 15297434 Review.

3

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.

Kapoor D, Goodwin E, Channer KS, Jones TH. Kapoor D, et al. Among authors: jones th. Eur J Endocrinol. 2006 Jun;154(6):899-906. doi: 10.1530/eje.1.02166. Eur J Endocrinol. 2006. PMID: 16728551 Clinical Trial.

4

A new 2% testosterone gel formulation: a comparison with currently available topical preparations.

Arver S, Stief C, de la Rosette J, Jones TH, Neijber A, Carrara D. Arver S, et al. Among authors: jones th. Andrology. 2018 May;6(3):396-407. doi: 10.1111/andr.12487. Epub 2018 Mar 30. Andrology. 2018. PMID: 29600542 Review.

5

Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.

Malkin CJ, Pugh PJ, Morris PD, Kerry KE, Jones RD, Jones TH, Channer KS. Malkin CJ, et al. Among authors: jones rd, jones th. Heart. 2004 Aug;90(8):871-6. doi: 10.1136/hrt.2003.021121. Heart. 2004. PMID: 15253956 Free PMC article. Clinical Trial.

6

Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone.

Hall J, Jones RD, Jones TH, Channer KS, Peers C. Hall J, et al. Among authors: jones rd, jones th. Endocrinology. 2006 Jun;147(6):2675-80. doi: 10.1210/en.2005-1243. Epub 2006 Mar 9. Endocrinology. 2006. PMID: 16527846

7

Testosterone does not adversely affect fibrinogen or tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1) levels in 46 men with chronic stable angina.

Smith AM, English KM, Malkin CJ, Jones RD, Jones TH, Channer KS. Smith AM, et al. Among authors: jones rd, jones th. Eur J Endocrinol. 2005 Feb;152(2):285-91. doi: 10.1530/eje.1.01848. Eur J Endocrinol. 2005. PMID: 15745938 Clinical Trial.

8

Pharmacokinetics and tolerability of a bioadhesive buccal testosterone tablet in hypogonadal men.

Ross RJ, Jabbar A, Jones TH, Roberts B, Dunkley K, Hall J, Long A, Levine H, Cullen DR. Ross RJ, et al. Among authors: jones th. Eur J Endocrinol. 2004 Jan;150(1):57-63. doi: 10.1530/eje.0.1500057. Eur J Endocrinol. 2004. PMID: 14713280 Clinical Trial.

9

Testosterone inhibits the prostaglandin F2alpha-mediated increase in intracellular calcium in A7r5 aortic smooth muscle cells: evidence of an antagonistic action upon store-operated calcium channels.

Jones RD, Ruban LN, Morton IE, Roberts SA, English KM, Channer KS, Jones TH. Jones RD, et al. Among authors: jones th. J Endocrinol. 2003 Sep;178(3):381-93. doi: 10.1677/joe.0.1780381. J Endocrinol. 2003. PMID: 12967331

10

Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover.

Guo CY, Jones TH, Eastell R. Guo CY, et al. Among authors: jones th. J Clin Endocrinol Metab. 1997 Feb;82(2):658-65. doi: 10.1210/jcem.82.2.3758. J Clin Endocrinol Metab. 1997. PMID: 9024272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results